Locations
-
DCI
INTERNAL MEDICINE
26 RESEARCH WAY,
EAST SETAUKET,
NY 11733-3453.
Ph.: 631-444-0580
Fax: 631-444-0562


Selected Publications
1. Jeremias A, Albirini A, Ziada KM, Chew DP, Brener SJ, Topol EJ, Ellis SG. Prognostic significance of creatine kinase-MB elevation following percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J 2002;143:1040-1045.
2. Jeremias A, Dusa C, Forudi F, Jacobsen DW, Vince DG, Nissen SE, Tuzcu EM. N-Acetyl-Cysteine in the prevention of vascular restenosis after percutaneous balloon angioplasty. Int J Cardiol 2004;95:255-60.
3. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, Ho KKL, Cohen DJ, Cutlip DE, Carrozza JP. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004;109:1930-32.
4. Jeremias A, Baim DS, Ho KKL, Chauhan M, Carrozza JP, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE. Differential mortality risk of post-procedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol 2004;44:1210-4.
5. Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, Hassan AH, Maehara A, Yeung AC, Pasterkamp G, Fitzgerald PJ, Yock PG. Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 2005;65:233-9.
6. Jeremias A, Gibson CM. Alternative causes for elevated troponin levels when acute coronary syndromes are excluded. Ann Int Med 2005;142:786-91.
7. Kirtane AJ, Rahman A, Martinezclark P, Jeremias A, Manning WJ. Survey of practice patterns in the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. Am J Cardiol 2006;97:891-3.
8. Kumar R, Lee TT, Jeremias A, Ruisi CP, Sylvia B, Magallon J, Kirtane AJ, Bigelow B, Abrahamson M, Pinto DS, Ho KK, Cohen DJ, Carrozza JP Jr, Cutlip DE. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients. Am J Cardiol 2007;100:1187-91.
9. Jeremias A, Ruisi CP, Kirtane AJ, Lee T, Sylvia B, Pinto DS, Ho KKL, Cutlip DE, Carrozza JP Jr., Cohen DC. Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the "real world". Coron Artery Dis 2008;19:111-5.
10. Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DC. Prevalence and prognostic significance of pre-procedure cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the EVENT registry. Circulation 2008;118:632-8.
11. Jeremias A, Kirtane AJ. Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention. Ann Intern Med2008;148:234-8
12. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization on mortality in patients with non-acute coronary artery disease. Am J Med 2009;122:152-61.
Personal Statement
Director, Vascular Medicine and Peripheral Intervention for the Stony Brook University Heart Center